Metabolomic Technologies Inc. Receives US Patent Covering Methods of Assessment of Colorectal Cancer and Colorectal Polyps by Measurement of Metabolites in Urine
MTI received notice from the USPTO that patent number 10,267,800 entitled, "Methods for the Assessment of Colorectal Cancer and Colorectal Polyps by Measurement of Metabolites in Urine" has been issued on April 23, 2019. The patent covers fundamental claims describing methods of analyzing patient's urine to detect colorectal cancer and precancerous polyps. Patents for PolypDx™ have also been issed in Japan, Hong Kong, throughout Europe, Canada, and Australia.